Advanced Enzyme [ADVENZYMES] vs Tanfac Industries [TANFACIND] Detailed Stock Comparison

Advanced Enzyme

NSE
Loading...

Tanfac Industries

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Advanced Enzyme wins in 12 metrics, Tanfac Industries wins in 8 metrics, with 0 ties. Advanced Enzyme appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAdvanced EnzymeTanfac IndustriesBetter
P/E Ratio (TTM)27.1947.66Advanced Enzyme
Price-to-Book Ratio2.6114.73Advanced Enzyme
Debt-to-Equity Ratio2.6813.28Advanced Enzyme
PEG Ratio1.590.67Tanfac Industries
EV/EBITDA17.0135.45Advanced Enzyme
Profit Margin (TTM)20.48%15.83%Advanced Enzyme
Operating Margin (TTM)25.18%19.10%Advanced Enzyme
EBITDA Margin (TTM)25.18%19.10%Advanced Enzyme
Return on Equity8.93%32.50%Tanfac Industries
Return on Assets (TTM)8.09%20.50%Tanfac Industries
Free Cash Flow (TTM)$1.08B$-641.87MAdvanced Enzyme
Dividend Yield1.56%0.34%Advanced Enzyme
1-Year Return-32.76%131.94%Tanfac Industries
Price-to-Sales Ratio (TTM)5.568.25Advanced Enzyme
Enterprise Value$32.05B$46.00BTanfac Industries
EV/Revenue Ratio4.808.26Advanced Enzyme
Gross Profit Margin (TTM)73.08%38.17%Advanced Enzyme
Revenue per Share (TTM)$60$558Tanfac Industries
Earnings per Share (Diluted)$12.21$96.67Tanfac Industries
Beta (Stock Volatility)0.37-0.19Tanfac Industries
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Advanced Enzyme vs Tanfac Industries Stock Performance Analysis

Loading Price Chart...

Advanced Enzyme
Tanfac Industries
Advanced Enzyme Stock Overview | Tanfac Industries Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Advanced Enzyme-0.24%3.38%-2.43%-2.12%12.15%-5.66%
Tanfac Industries1.41%-5.45%-4.11%17.60%55.08%50.48%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Advanced Enzyme-32.76%17.43%-7.98%16.16%16.16%16.16%
Tanfac Industries131.94%432.80%2,580.25%9,559.01%13,653.28%9,448.91%

News Based Sentiment: Advanced Enzyme vs Tanfac Industries

Advanced Enzyme

News based Sentiment: POSITIVE

The company reported strong financial results in Q3 FY24 with double-digit growth in revenue and profit, and announced a share buyback, signaling confidence in future performance. These developments collectively strengthen the investment case and suggest a positive outlook.

View Advanced Enzyme News Sentiment Analysis

Tanfac Industries

News based Sentiment: MIXED

September was a month of conflicting signals for Tanfac Industries. While the company reported positive Q1 FY26 results, concerns about its valuation intensified, leading to a downgrade from StockInvest.us. This creates a mixed investment picture, requiring careful consideration of both the company's strengths and weaknesses.

View Tanfac Industries News Sentiment Analysis

Performance & Financial Health Analysis: Advanced Enzyme vs Tanfac Industries

MetricADVENZYMESTANFACIND
Market Information
Market Cap i₹37.82B₹47.48B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i172,3148,318
90 Day Avg. Volume i872,2829,739
Last Close₹330.80₹4,607.35
52 Week Range₹257.90 - ₹520.70₹2,510.00 - ₹5,064.30
% from 52W High-36.47%-9.02%
All-Time High₹571.00 (Sep 16, 2024)₹5,064.30 (Aug 29, 2025)
% from All-Time High-42.07%-9.02%
Growth Metrics
Quarterly Revenue Growth0.20%0.67%
Quarterly Earnings Growth0.17%0.80%
Financial Health
Profit Margin (TTM) i0.20%0.16%
Operating Margin (TTM) i0.25%0.19%
Return on Equity (TTM) i0.09%0.33%
Debt to Equity (MRQ) i2.6813.28
Cash & Liquidity
Book Value per Share (MRQ)₹127.00₹312.76
Cash per Share (MRQ)₹52.94₹37.20
Operating Cash Flow (TTM) i₹1.70B₹328.42M
Levered Free Cash Flow (TTM) i₹1.31B₹-932,025,344
Dividends
Last 12-Month Dividend Yield i1.56%0.34%
Last 12-Month Dividend i₹5.20₹16.00

Valuation & Enterprise Metrics Analysis: Advanced Enzyme vs Tanfac Industries

MetricADVENZYMESTANFACIND
Price Ratios
P/E Ratio (TTM) i27.1947.66
Forward P/E i26.67N/A
PEG Ratio i1.590.67
Price to Sales (TTM) i5.568.25
Price to Book (MRQ) i2.6114.73
Market Capitalization
Market Capitalization i₹37.82B₹47.48B
Enterprise Value i₹32.05B₹46.00B
Enterprise Value Metrics
Enterprise to Revenue i4.808.26
Enterprise to EBITDA i17.0135.45
Risk & Other Metrics
Beta i0.37-0.19
Book Value per Share (MRQ) i₹127.00₹312.76

Financial Statements Comparison: Advanced Enzyme vs Tanfac Industries

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ADVENZYMESTANFACIND
Revenue/Sales i₹1.86B₹1.76B
Cost of Goods Sold i₹500.49M₹1.09B
Gross Profit i₹1.36B₹671.84M
Research & Development iN/AN/A
Operating Income (EBIT) i₹468.14M₹250.88M
EBITDA i₹652.82M₹299.13M
Pre-Tax Income i₹549.00M₹246.48M
Income Tax i₹144.60M₹52.96M
Net Income (Profit) i₹404.40M₹193.52M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ADVENZYMESTANFACIND
Cash & Equivalents i₹942.25M₹301.18M
Total Current Assets i₹8.80B₹2.46B
Total Current Liabilities i₹967.55M₹1.08B
Long-Term Debt i₹209.17MN/A
Total Shareholders Equity i₹14.69B₹3.12B
Retained Earnings i₹11.53B₹2.62B
Property, Plant & Equipment i₹2.93B₹1.68B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ADVENZYMESTANFACIND
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricADVENZYMESTANFACIND
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i172,3148,318
Average Daily Volume (90 Day) i872,2829,739
Shares Outstanding i111.88M9.98M
Float Shares i29.32M3.51M
% Held by Insiders i0.56%0.75%
% Held by Institutions i0.21%0.00%

Dividend Analysis & Yield Comparison: Advanced Enzyme vs Tanfac Industries

MetricADVENZYMESTANFACIND
Last 12-Month Dividend i₹5.20₹16.00
Last 12-Month Dividend Yield i1.56%0.34%
3-Year Avg Annual Dividend i₹5.43₹7.50
3-Year Avg Dividend Yield i0.75%0.30%
3-Year Total Dividends i₹16.30₹22.50
Ex-Dividend DateJul 23, 2025Sep 17, 2025